1. Update on the Diagnosis and Management of CTEPH in Latin America

2. Clinical Classification of PH

3. Pulmonary Endarterectomy Surgery: Scar Tissue Removal

4. Results of PE

5. History of PE Is a Risk Factor for CTEPH

6. Diagnosis of CTEPH (SCAR): A Step-Wise Process

7. SCAR: S = Suspect

8. SCAR: C = Confirm

9. SCAR: AR = Assess Risk

10. CTEPH Is Not Just a Clot Problem

11. CTEPH Is Not Just a Clot Problem (cont)

12. CTEPH Treatment Algorithm

13. Key Principles Regarding the Management of CTEPH

14. Key Principles Regarding the Management of CTEPH (cont)

15. CTEPH Treatment: Patients Deemed Operable

16. CTEPH Treatment Algorithm (cont)[a]

17. Pulmonary Endarterectomy Specimen: Significant Thromboembolic Material

18. UCSD Experience With Pulmonary Endarterectomy

19. UCSD Experience With Pulmonary Endarterectomy (cont)

20. CTEPH: Determining Operability

21. Potentially Inoperable Patient With CTEPH

22. CTEPH Treatment Algorithm (cont)

23. Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CHEST-1)

24. Riociguat: Mechanism of Action

25. CHEST-1*: Mean Change From Baseline in 6MWD

26. CHEST-2: Long-Term Extension Study of Riociguat for CTEPH

27. AEs in the CHEST-2 Study

28. Potential Scenarios for Targeted Medical Therapy in CTEPH

29. Patient Offered BPA

30. Pulmonary Endarterectomy and BPA: Comments

31. Summary and Conclusions

32. Abbreviations

33. Abbreviations (cont)